Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38087
CAS Number:
145525-41-3
Mitiglinida de calcio
Purity:
≥ 98 % (HPLC)
Synonym(s):
Sal de calcio del ácido (a S ,3a R ,7a S )-octahidro-G-oxo-a-(fenilmetil)-2 H -isoindol-2-butanoico, Sal hemicálcica de mitiglinida
Documents
$145.52 /100 mg
Tamaño
Request Bulk Quote
Product Information

Conservar bajo gas inerte.

Synonyms
Sal de calcio del ácido (a S ,3a R ,7a S )-octahidro-G-oxo-a-(fenilmetil)-2 H -isoindol-2-butanoico, Sal hemicálcica de mitiglinida
CAS Number
145525-41-3
Purity
≥ 98 % (HPLC)
Molecular Formula
C38H48CaN2O6
Molecular Weight
668.89
MDL Number
MFCD09955408
PubChem ID
53394913
Melting Point
184 - 186 °C
Appearance
Polvo blanco a casi blanco a cristal.
Optical Rotation
[a] 20 D = 5 - 9 ° (C=1, MeOH) (calculado sobre sustancia anh.)
Conditions
Conservar entre 2 y 8 °C.
General Information
Synonyms
Sal de calcio del ácido (a S ,3a R ,7a S )-octahidro-G-oxo-a-(fenilmetil)-2 H -isoindol-2-butanoico, Sal hemicálcica de mitiglinida
CAS Number
145525-41-3
Purity
≥ 98 % (HPLC)
Molecular Formula
C38H48CaN2O6
Molecular Weight
668.89
MDL Number
MFCD09955408
PubChem ID
53394913
Melting Point
184 - 186 °C
Appearance
Polvo blanco a casi blanco a cristal.
Optical Rotation
[a] 20 D = 5 - 9 ° (C=1, MeOH) (calculado sobre sustancia anh.)
Conditions
Conservar entre 2 y 8 °C.
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Mitiglinide calcium is widely utilized in research focused on:

  • Diabetes Management: This compound is primarily used in the treatment of type 2 diabetes, helping to regulate blood sugar levels by stimulating insulin secretion from the pancreas.
  • Pharmaceutical Development: Researchers are exploring its potential in developing new formulations that enhance the bioavailability and effectiveness of diabetes medications.
  • Clinical Trials: Mitiglinide calcium is often involved in clinical studies aimed at assessing its long-term effects and safety profiles in diverse patient populations.
  • Combination Therapies: It is being investigated for use in combination with other antidiabetic agents to improve glycemic control and reduce side effects.
  • Patient Education: The compound is also a focal point in educational materials for healthcare providers, emphasizing its role in personalized diabetes care and management strategies.

Citas